<DOC>
	<DOCNO>NCT00427921</DOCNO>
	<brief_summary>To make adalimumab available subject suffer moderately severely active Crohn 's Disease ( CD ) expand safety information adalimumab . The study also assess change Patient Reported Outcome Measures baseline .</brief_summary>
	<brief_title>Human Anti-TNF Monoclonal Antibody Adalimumab Canadian Subjects With Moderate Severe Crohn 's Disease ( ACCESS )</brief_title>
	<detailed_description>This Phase 3 , multicenter , open-label , Early Access Study induction regimen adalimumab 160 mg subcutaneous ( SC ) Baseline 80 mg SC Week 2 , follow maintenance dose 40 mg every week ( eow ) start Week 4 subject moderately severely active Crohn 's Disease ( CD ) eligible receive biologic therapy fail respond , lose response , intolerant infliximab . Failure prior therapy determine Investigator . Subjects 8-week wash-out period prior Baseline last dose infliximab .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Males females 18 year age old Females : Not childbearing potential OR Practicing approve birth control throughout study 150 day study completion Diagnosis moderate severe CD great 16 week prior screen ; Crohn 's Disease Activity Index score &gt; 220 OR Harvey Bradshaw Index equal high 7 , refractory optimal conventional therapy , 5aminosalicylic acid ( 5ASA ) , glucocorticoid , immunosuppressive therapy ( azathioprine , 6MP MTX ) Subjects failed prior infliximab therapy ( determined primary investigator ) , include never clinically respond ( `` primary nonresponders '' ) History cancer skin cervical cancer History opportunistic infection , central nervous system ( CNS ) demyelinate disease , chronic viral hepatitis , untreated tuberculosis Subjects , poorly control medical condition Subjects prior exposure TysabriÂ® ( natalizumab ) Subjects receive investigational agent past 30 day 5 halflives prior screen ( whichever longer ) Female subject pregnant breastfeed consider become pregnant study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>